NCT01235988View on ClinicalTrials.gov

Meta-analysis - Eltrombopag

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Thrombocytopaenia

Interventions

DRUG

Eltrombopag

Eltrombopag 50mg \& standard of care

DRUG

Placebo

Placebo + standard of care

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY